As global markets navigate a busy earnings season and economic uncertainties, major indices like the Nasdaq Composite and S&P 500 have experienced volatility, with growth stocks underperforming compared to value shares. Amidst these fluctuations, dividend stocks continue to attract investors seeking stability and income in their portfolios. In such an environment, a good dividend stock is often characterized by consistent payouts and strong financial health, providing a buffer against market turbulence while offering potential for long-term growth.
Name | Dividend Yield | Dividend Rating |
Guaranty Trust Holding (NGSE:GTCO) | 6.85% | ★★★★★★ |
Peoples Bancorp (NasdaqGS:PEBO) | 4.52% | ★★★★★★ |
Innotech (TSE:9880) | 4.75% | ★★★★★★ |
CAC Holdings (TSE:4725) | 4.53% | ★★★★★★ |
Business Brain Showa-Ota (TSE:9658) | 4.12% | ★★★★★★ |
James Latham (AIM:LTHM) | 5.94% | ★★★★★★ |
Citizens & Northern (NasdaqCM:CZNC) | 5.44% | ★★★★★★ |
GakkyushaLtd (TSE:9769) | 4.59% | ★★★★★★ |
KurimotoLtd (TSE:5602) | 4.99% | ★★★★★★ |
Banque Cantonale Vaudoise (SWX:BCVN) | 5.00% | ★★★★★★ |
Click here to see the full list of 1933 stocks from our Top Dividend Stocks screener.
Let's review some notable picks from our screened stocks.
Simply Wall St Dividend Rating: ★★★★☆☆
Overview: Xin Point Holdings Limited is an investment holding company that manufactures and sells automotive and electronic components across China, North America, Europe, and other international markets, with a market cap of HK$3.65 billion.
Operations: The company's revenue primarily comes from the manufacture and sale of automotive and electronic components, totaling CN¥3.23 billion.
Dividend Yield: 8.6%
Xin Point Holdings offers a compelling dividend profile, with its dividend yield in the top 25% of Hong Kong market payers. Dividends are well-covered by earnings and cash flows, with payout ratios at 61.9% and 49.2%, respectively. However, the company has a volatile dividend history over its seven-year payment period. Recent financials show growth, with half-year sales rising to CNY 1.65 billion and net income increasing to CNY 322.16 million year-on-year.
Simply Wall St Dividend Rating: ★★★★☆☆
Overview: Tong Ren Tang Technologies Co. Ltd. manufactures and sells Chinese medicine products both in Mainland China and internationally, with a market cap of HK$6.90 billion.
Operations: Tong Ren Tang Technologies Co. Ltd.'s revenue is primarily derived from its own operations, contributing CN¥4.29 billion, and from Tong Ren Tang Chinese Medicine, which adds CN¥1.26 billion.
Dividend Yield: 3.5%
Tong Ren Tang Technologies maintains a stable dividend history over the past decade, with dividends growing and remaining reliable. However, its dividend yield of 3.51% is lower than top-tier payers in Hong Kong and not well-covered by free cash flows despite a low payout ratio of 35.4%. Recent financials show improved earnings, with net income rising to CNY 428.75 million for the first half of 2024 from CNY 368.15 million year-on-year.
Simply Wall St Dividend Rating: ★★★★☆☆
Overview: Dr. Wu Skincare Co., Ltd. focuses on the research, development, production, wholesale, and retail of cosmetics and skincare products in Taiwan and internationally with a market cap of NT$6.73 billion.
Operations: Dr. Wu Skincare Co., Ltd.'s revenue from Personal Products amounts to NT$1.22 billion.
Dividend Yield: 5%
Dr. Wu Skincare's dividend yield of 4.98% places it among the top 25% in Taiwan, though its track record is less stable, with payouts being volatile over nine years. Despite this, dividends are covered by earnings and cash flows with payout ratios of 75.3% and 65%, respectively. Recent financials show a net income of TWD 238.8 million for the first half of 2024, reflecting growth from TWD 185.24 million year-on-year, supporting dividend sustainability in the near term.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com